BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7460034)

  • 1. [A new potential non-steroidal antirheumatic agent. Benzofenac VUFB].
    Grimová J; Kuchar M; Pavlíková L; Nĕmecek O
    Cesk Farm; 1980 Nov; 29(8-9):305-8. PubMed ID: 7460034
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory activity of catalase in carrageenin edema, manganese chloride edema and adjuvant arthritis of rats.
    Hirschelmann R; Bekemeier H
    Agents Actions Suppl; 1982; 10():157-72. PubMed ID: 6956216
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental therapy of adjuvant disease].
    Saratikov AA; Vengerovskiĭ AI
    Farmakol Toksikol; 1983; 46(1):116-20. PubMed ID: 6337869
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with Voltaren a new nonsteroid antirheumatic agent].
    Ciccolunghi SN; Levi B; Chaudri HA
    Wien Med Wochenschr; 1975 Jan; 125(4):66-70. PubMed ID: 1093333
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of cytogenin, a novel anti-arthritic agent, on type II collagen-induced arthritis in DBA/1J mice and adjuvant arthritis in Lewis rats.
    Hirano S; Wakazono K; Agata N; Mase T; Yamamoto R; Matsufuji M; Sakata N; Iguchi H; Tone H; Ishizuka M
    Int J Tissue React; 1994; 16(4):155-62. PubMed ID: 7797401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calophyllolide--a new non-steroidal anti-inflammatory agent.
    Bhalla TN; Saxena RC; Nigam SK; Misra G; Bhargava KP
    Indian J Med Res; 1980 Nov; 72():762-5. PubMed ID: 7203581
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effects of antiarthritic and other pharmacological agents in the 18-hour arthritis and carrageenan edema tests in rats.
    Sofia RD; Danielsen L; Vassar HB
    Pharmacol Res Commun; 1979 Feb; 11(2):179-93. PubMed ID: 35795
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative characteristics of the anti-inflammatory and analgesic effects of voltaren, indomethacin and benzofurocaine in adjuvant disease in rats].
    Stepaniuk GI; Stoliarchuk AA; Lutsiuk NB; Smirnova OV; Cherviak MN
    Patol Fiziol Eksp Ter; 1986; (5):78-82. PubMed ID: 3491973
    [No Abstract]   [Full Text] [Related]  

  • 9. [Animal experiments with pirprofen].
    Maier R
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):159-64. PubMed ID: 3872823
    [No Abstract]   [Full Text] [Related]  

  • 10. Copper complexes and experimental-induced inflammation and arthritis.
    Lewis EJ; West GB
    Agents Actions Suppl; 1981; 8():339-58. PubMed ID: 6781236
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological profile of the novel potent antirheumatic 4-(2',4'-difluorobiphenyl-4-yl)-2-methyl-4-oxobutanoic acid.
    Panajotova V; Andĕrova E; Jandera A; Kuchar M
    Arzneimittelforschung; 1997 May; 47(5):648-52. PubMed ID: 9205780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological study on "saiko-prescriptions" (3). Actions on experimental inflammation in rats].
    Kato M; Hayashi M; Hayashi M; Maeda T
    Yakugaku Zasshi; 1983 Apr; 103(4):466-72. PubMed ID: 6631677
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on two new derivatives of N-aralkyl-o-ethoxybenzamides: Part I--pharmacological studies on anti-inflammatory activities.
    Naik SR; Sheth UK; Bhanumati S; Sattur PB
    Indian J Exp Biol; 1978 Nov; 16(11):1169-74. PubMed ID: 312273
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of borjatriol on established adjuvant arthritis.
    Villar A; Salom R; Alcaraz MJ
    Pharmazie; 1983 Aug; 38(8):566. PubMed ID: 6634930
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of the antirheumatic benzofenac VUFB, in experimental animals and man, in relation to the species specificity of pharmacokinetics and biotransformation].
    Grimová J; Roubal Z; Koruna I; Nĕmecek O
    Cas Lek Cesk; 1982 Sep; 121(34-35):1078-82. PubMed ID: 7127389
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental and clinical study of a new non-steroidal anti-inflammatory agent: butoxyphenylacetylhydroxamic acid (Droxaryl)].
    Van Cauwenberge H
    Rev Rhum Mal Osteoartic; 1967 Sep; 34(9):480-8. PubMed ID: 4384373
    [No Abstract]   [Full Text] [Related]  

  • 17. Allergy to bufexamac.
    Van Hecke E
    Arch Belg Dermatol; 1973; 29(4):301-3. PubMed ID: 4802391
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive foot swelling in BUF rats. A new animal model for screening of anti-inflammatory and anti-rheumatic drugs.
    Ishizuki S; Kanda N; Kaneta S; Fujihira E
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):303-14. PubMed ID: 6508437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on anti-inflammatory activity of two potent indan-1-acetic acids.
    Roy A; Gupta JK; Lahiri SC
    Indian J Physiol Pharmacol; 1982; 26(3):207-14. PubMed ID: 7174067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of leaf and twig of Tripterygium wilfordii on paw edema in mice.
    Yu L; Ao M; Wan J; Zhang Y
    Fitoterapia; 2008 Dec; 79(7-8):529-32. PubMed ID: 18672035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.